SOLIDEX™ CD25+ Cell Isolation Solution
Introduction of SOLIDEX™ CD25+ Cell Isolation Solution
CD25+ Cells primarily refer to immune cells expressing the CD25 marker, particularly regulatory T cells (Treg, CD4+CD25+FoxP3+). CD25 is a high-affinity IL-2 receptor subunit on the surface of T cells, widely used for identifying and isolating Treg cells. CD25+ cells are typically detected in conjunction with CD4 and FoxP3 markers to confirm the Treg cell phenotype. GeneMedi provides CD25 magnetic beads for the positive selection or depletion of CD25+ cells, catering to various research and therapeutic needs.
Isolation method of SOLIDEX™ CD25+ Cell Isolation Solution
- Positive Selection
- Depletion
Research Applications:
Anti-CD25 magnetic beads are used to isolate pure CD4/CD25 Treg cells for in vitro expansion, functional analysis, and subsequent flow cytometry assessment of their suppressive activity. This reveals the mechanisms of Treg cells in immune regulation.
Clinical Applications:
After CD8 cell depletion, CD25+ cells are highly enriched from the leukocytes of healthy donors, yielding polyclonal Tregs. This supports clinical-grade expansion for adoptive immunotherapy. Additionally, large-scale isolation of functional CD25+ Treg cells under clinical-grade conditions is suitable for processing large sample sizes. Infusion of clinical-grade enriched Treg cells can delay experimental graft-versus-host disease (GvHD) and support Treg transfer therapy to improve intestinal inflammation in ulcerative colitis patients.
Cat.No | Product Name | Products Information |
---|---|---|
GM-Tg-hg-T03313-iso-nanoIMB | Human CD25 Nano-mag Beads (Column-Based) | Details |
GM-Tg-hg-T03313-iso-nanoIMB-CF | Human CD25 Nano-mag Beads (Column-Free) | Details |
GM-Tg-hg-T03313-iso-rel-kit | Indirect Releasable Human CD25+ Cell Isolation Kit (Column-Based) | Details |
GM-Tg-hg-T03313-iso-rel-kit-CF | Indirect Releasable Human CD25+ Cell Isolation Kit (Column-Free) | Details |
GM-Tg-hg-T03313-iso-kit | Indirect Human CD25+ Cell Isolation Kit (Column-Based) | Details |
GM-Tg-hg-T03313-iso-kit-CF | Indirect Human CD25+ Cell Isolation Kit (Column-Free) | Details |
Clinical Applications:
CD14/CD25 depletion removes myeloid cells and Tregs, enhancing the efficacy of CAR-T cell therapy in treating relapsed/refractory non-Hodgkin lymphoma by reducing immunosuppression and improving tumor-killing efficiency. Additionally, clinical research shows that CD25 Treg depletion in donor lymphocyte infusion (DLI) during Phase I trials after allogeneic stem cell transplantation for relapse improves graft-versus-tumor (GvT) effects, boosts donor T cell GVL response, and reduces GvHD risk .
Cat.No | Product Name | Products Information |
---|---|---|
GM-Tg-hg-T03313-dep-nanoIMB | Human CD25+ Cell Depletion Nano-mag Beads (Column-Based) | Details |
GM-Tg-hg-T03313-dep-kit | Indirect Human CD25+ Cell Depletion Kit (Column-Based) | Details |